Cargando…

Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions

Purpose: This study aims to investigate preventability criteria of adverse drug reactions (ADRs) involving non-steroidal anti-inflammatory drugs (NSAIDs) by analyzing individual case safety reports (ICSRs) sent through Campania region (Italy) spontaneous reporting system from July 2012 to October 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Sessa, Maurizio, Sportiello, Liberata, Mascolo, Annamaria, Scavone, Cristina, Gallipoli, Silvia, di Mauro, Gabriella, Cimmaruta, Daniela, Rafaniello, Concetta, Capuano, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445158/
https://www.ncbi.nlm.nih.gov/pubmed/28603499
http://dx.doi.org/10.3389/fphar.2017.00305
_version_ 1783238825889234944
author Sessa, Maurizio
Sportiello, Liberata
Mascolo, Annamaria
Scavone, Cristina
Gallipoli, Silvia
di Mauro, Gabriella
Cimmaruta, Daniela
Rafaniello, Concetta
Capuano, Annalisa
author_facet Sessa, Maurizio
Sportiello, Liberata
Mascolo, Annamaria
Scavone, Cristina
Gallipoli, Silvia
di Mauro, Gabriella
Cimmaruta, Daniela
Rafaniello, Concetta
Capuano, Annalisa
author_sort Sessa, Maurizio
collection PubMed
description Purpose: This study aims to investigate preventability criteria of adverse drug reactions (ADRs) involving non-steroidal anti-inflammatory drugs (NSAIDs) by analyzing individual case safety reports (ICSRs) sent through Campania region (Italy) spontaneous reporting system from July 2012 to October 2016. Methods: For all the ICSRs that reported NSAIDs as suspected drug, a trained multidisciplinary team of Campania Pharmacovigilance Regional Centre composed of clinical pharmacologists and pharmacists with pluriannual experience in Pharmacovigilance assessed preventability by using the P-method. Results: In all 19,039 ICSRs were sent to Campania Pharmacovigilance Regional Centre, of which 550 reported NSAIDs as suspected drug. In total, 94 cases (17.1%) out of 550 ICSRs were preventable. In the 94 preventable cases, 201 critical criteria were detected of which 182/201 (90.5%) related to healthcare professionals' practices, 0/201 (0.0%) to drug quality, and 19/201 (9.5%) to patient behavior. The most detected critical criteria were the necessary medication not given (52/182; 28.6%), labeled drug–drug interaction (36/182; 19.7%), incorrect drug administration duration (31/182; 16.9%), wrong indication (26/182; 14.2%), therapeutic duplication (18/182; 10.0%), and documented hypersensitivity to administered drug or drug class (10/182; 5.6%). In seventeen (18.1%) preventable cases, there were 19 critical criteria involving non-compliance (15/19 critical criteria; 78.9%) and self-medication with the non-over-the-counter drugs (4/19 critical criteria; 21.1%). In all, 17 out 94 (18.1%) preventable cases involved over-the-counter drugs. Conclusion: A call for action for Campania Pharmacovigilance Regional Centre is necessary in order to promote initiatives to increase the awareness of healthcare professionals and citizens on the risk associated with inappropriate use of NSAIDs.
format Online
Article
Text
id pubmed-5445158
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54451582017-06-09 Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions Sessa, Maurizio Sportiello, Liberata Mascolo, Annamaria Scavone, Cristina Gallipoli, Silvia di Mauro, Gabriella Cimmaruta, Daniela Rafaniello, Concetta Capuano, Annalisa Front Pharmacol Pharmacology Purpose: This study aims to investigate preventability criteria of adverse drug reactions (ADRs) involving non-steroidal anti-inflammatory drugs (NSAIDs) by analyzing individual case safety reports (ICSRs) sent through Campania region (Italy) spontaneous reporting system from July 2012 to October 2016. Methods: For all the ICSRs that reported NSAIDs as suspected drug, a trained multidisciplinary team of Campania Pharmacovigilance Regional Centre composed of clinical pharmacologists and pharmacists with pluriannual experience in Pharmacovigilance assessed preventability by using the P-method. Results: In all 19,039 ICSRs were sent to Campania Pharmacovigilance Regional Centre, of which 550 reported NSAIDs as suspected drug. In total, 94 cases (17.1%) out of 550 ICSRs were preventable. In the 94 preventable cases, 201 critical criteria were detected of which 182/201 (90.5%) related to healthcare professionals' practices, 0/201 (0.0%) to drug quality, and 19/201 (9.5%) to patient behavior. The most detected critical criteria were the necessary medication not given (52/182; 28.6%), labeled drug–drug interaction (36/182; 19.7%), incorrect drug administration duration (31/182; 16.9%), wrong indication (26/182; 14.2%), therapeutic duplication (18/182; 10.0%), and documented hypersensitivity to administered drug or drug class (10/182; 5.6%). In seventeen (18.1%) preventable cases, there were 19 critical criteria involving non-compliance (15/19 critical criteria; 78.9%) and self-medication with the non-over-the-counter drugs (4/19 critical criteria; 21.1%). In all, 17 out 94 (18.1%) preventable cases involved over-the-counter drugs. Conclusion: A call for action for Campania Pharmacovigilance Regional Centre is necessary in order to promote initiatives to increase the awareness of healthcare professionals and citizens on the risk associated with inappropriate use of NSAIDs. Frontiers Media S.A. 2017-05-26 /pmc/articles/PMC5445158/ /pubmed/28603499 http://dx.doi.org/10.3389/fphar.2017.00305 Text en Copyright © 2017 Sessa, Sportiello, Mascolo, Scavone, Gallipoli, di Mauro, Cimmaruta, Rafaniello and Capuano. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Sessa, Maurizio
Sportiello, Liberata
Mascolo, Annamaria
Scavone, Cristina
Gallipoli, Silvia
di Mauro, Gabriella
Cimmaruta, Daniela
Rafaniello, Concetta
Capuano, Annalisa
Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
title Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
title_full Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
title_fullStr Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
title_full_unstemmed Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
title_short Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
title_sort campania preventability assessment committee (italy): a focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445158/
https://www.ncbi.nlm.nih.gov/pubmed/28603499
http://dx.doi.org/10.3389/fphar.2017.00305
work_keys_str_mv AT sessamaurizio campaniapreventabilityassessmentcommitteeitalyafocusonthepreventabilityofnonsteroidalantiinflammatorydrugsadversedrugreactions
AT sportielloliberata campaniapreventabilityassessmentcommitteeitalyafocusonthepreventabilityofnonsteroidalantiinflammatorydrugsadversedrugreactions
AT mascoloannamaria campaniapreventabilityassessmentcommitteeitalyafocusonthepreventabilityofnonsteroidalantiinflammatorydrugsadversedrugreactions
AT scavonecristina campaniapreventabilityassessmentcommitteeitalyafocusonthepreventabilityofnonsteroidalantiinflammatorydrugsadversedrugreactions
AT gallipolisilvia campaniapreventabilityassessmentcommitteeitalyafocusonthepreventabilityofnonsteroidalantiinflammatorydrugsadversedrugreactions
AT dimaurogabriella campaniapreventabilityassessmentcommitteeitalyafocusonthepreventabilityofnonsteroidalantiinflammatorydrugsadversedrugreactions
AT cimmarutadaniela campaniapreventabilityassessmentcommitteeitalyafocusonthepreventabilityofnonsteroidalantiinflammatorydrugsadversedrugreactions
AT rafanielloconcetta campaniapreventabilityassessmentcommitteeitalyafocusonthepreventabilityofnonsteroidalantiinflammatorydrugsadversedrugreactions
AT capuanoannalisa campaniapreventabilityassessmentcommitteeitalyafocusonthepreventabilityofnonsteroidalantiinflammatorydrugsadversedrugreactions